articleNature MedicineFeb 1, 2002Closed access

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

MGMarkus GubaPVPhilipp von BreitenbuchMSMarkus SteinbauerGEGudrun E. KoehlSFStefanie Flegel

University Hospital Regensburg · University of Regensburg

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,735
total citations
FWCI
30.48
Percentile
100%
References
43
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Immunosuppression
  • Angiogenesis
  • Vascular endothelial growth factor
  • Medicine
  • In vivo
  • Cancer research
  • Transplantation
  • Growth factor
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.